Sundrug Co.,Ltd.
Sundrug Co.,Ltd. (9989.T) Stock Overview
Explore Sundrug Co.,Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
463.1B
P/E Ratio
14.87
EPS (TTM)
$271.62
ROE
0.11%
9989.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Sundrug Co.,Ltd. (9989.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 32.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4692.80.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.87 and a market capitalization of 463.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.